#
Dexlansoprazole Delayed Release
  • Professionals
  • FDA PI

Dexlansoprazole Delayed Release

Dosage form: capsule, delayed release
Drug class:Proton pump inhibitors

Medically reviewed by Drugs.com. Last updated on Mar 1, 2022.

Indications and Usage for Dexlansoprazole Delayed Release

Healing of Erosive Esophagitis

Dexlansoprazole delayed-release capsules are indicated in patients 12 years of age and older for healing of all grades of erosive esophagitis (EE) for up to eight weeks.

Maintenance of Healed Erosive Esophagitis and Relief of Heartburn

Dexlansoprazole delayed-release capsules are indicated in patients 12 years of age and older to maintain healing of EE and relief of heartburn for up to six months in adults and 16 weeks in patients 12 to 17 years of age.

Treatment of Symptomatic Non-Erosive Gastroesophageal Reflux Disease

Dexlansoprazole delayed-release capsules are indicated in patients 12 years of age and older for the treatment o...